Robert E Hollingsworth

Title: The Innovations of Robert E Hollingsworth

Introduction

Robert E Hollingsworth is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of biotechnology, particularly in the area of genetic research. With a total of 2 patents, his work has implications for understanding complex biological pathways.

Latest Patents

Hollingsworth's latest patents include a groundbreaking invention related to the hedgehog signaling pathway. This invention pertains to a novel human patched-like gene (PTCH2), which has been cloned and sequenced for the first time. Several alternatively spliced mRNA forms of PTCH2 have been identified, including transcripts that lack segments thought to be involved in sonic hedgehog (SHH) binding. Additionally, the invention relates to the protein encoded by PTCH2, as well as to functional analogues and variants thereof. Another significant patent involves fusion proteins of mutants of cyclin E and their complexes with cyclin-dependent kinase 2 (Cdk2). This includes a polypeptide of the amino acid sequence of SEQ ID NO: 2, along with a composition that features the polypeptide bound to Cdk2.

Career Highlights

Throughout his career, Hollingsworth has worked with prominent companies such as Pharmacia & Upjohn Company and Karolinska Innovations AB. His experience in these organizations has allowed him to develop and refine his innovative ideas in biotechnology.

Collaborations

Hollingsworth has collaborated with notable individuals in his field, including Peter G Zaphiropoulos and Fahimeh Rahnama. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Robert E Hollingsworth's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the understanding of genetic pathways and their applications in medicine.